Please assess the completion status of the following clinical trial:

Trial Title: Therapeutic Effect of Sodium Intake Reduction in Treatment Resistant Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* individuals who agreed to participate in the study and submitted written informed consent~* individuals aged 20 or more years~* Hypertensive patients whose blood pressure is not controlled normally while taking three or more antihypertensive agents including diuretics~* Diuretics should be Hydrochlorothiazide or Indapamide~Exclusion Criteria:~* Systolic blood pressure ≥ 220 mmHg~* Chronic kidney disease: estimated Glomerular filtration rate by Modification of Diet in Renal Disease formula ≤ 30 mL/min~* Hyperkalemia (\>5.5 mmol/L) or hypokalemia (\<3.5 mmol/L)~* Hyponatremia (\<135 mmol/L)~* Major cardiovascular events (MI, unstable angina, coronary revascularization, stroke) within 6 month of screening~* Retinal bleeding within 3 months~* Heart failure stage 3 or 4~* Severe liver disease~* Pregnancy or women in the fertile age not using efficient contraceptive methods~* Alcoholism~* Renovascular disease

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sodium intake reduction and exercise (Type: ACTIVE_COMPARATOR): education of sodium intake reduction and regular exercise
- Exercise (Type: PLACEBO_COMPARATOR): education of regular exercise only

Based on this trial design, predict the completion outcome and termination type (if applicable).